The molecular architecture of Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester (C₂₆H₅₃NO₃, MW 427.7) is characterized by a highly branched, lipid-like structure containing a secondary amine center flanked by two flexible alkyl ester chains. At the core of the molecule, a central heptanoic acid scaffold is esterified at the carboxylic acid terminus with a sterically bulky 1-hexylnonyl (C15) secondary alcohol, forming a branched ester that contributes substantial lipophilicity (predicted density ~0.914 g/cm³) and influences the molecule‘s packing behavior in lipid-based formulations. At the ω-position of the heptanoyl chain, the carboxylic acid is derivatized as an amide with 4-hydroxybutylamine, introducing a secondary amine nitrogen and a terminal primary hydroxyl group. This 4-hydroxybutyl moiety provides both a nucleophilic alcohol handle and a hydrogen-bonding site, partially balancing the hydrophobic character of the two long alkyl domains. The presence of three heteroatom-containing functional groups—an ester carbonyl, a secondary amine, and a terminal alcohol—provides multiple sites for derivatization or intermolecular interactions, while the C15 and C7 alkyl chains provide the hydrophobic character necessary for lipid nanoparticle integration. This combination of a branched ester tail, an internal secondary amine, and a terminal hydroxyl group makes Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester a structurally distinctive lipid-like intermediate relevant to the synthesis of ionizable lipids for nucleic acid delivery applications.
Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester is an amino alcohol ester building block that has been primarily investigated as a synthetic intermediate in the construction of ionizable lipid libraries for lipid nanoparticle (LNP)-mediated nucleic acid delivery. The secondary amine in Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester serves as the critical ionizable center, designed to remain uncharged at physiological pH (7.4) while becoming protonated in the acidic endosomal environment (pH 5.0–6.5), thereby facilitating endosomal escape through the proton sponge effect and subsequent cytosolic delivery of mRNA or siRNA payloads. The branched 1-hexylnonyl ester tail in Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester imparts a characteristic conical molecular geometry that favors the formation of inverted hexagonal (HII) phase structures, a biophysical property that has been correlated with efficient membrane fusion and nucleic acid release. The terminal 4-hydroxybutyl group provides a synthetic handle for further derivatization. Structurally related amino alcohol lipidoids are pivotal in creating nucleic acid delivery systems and form a crucial component of nanolipid particles used for delivery vectors. The availability of Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester as a high-purity intermediate supports the rational design and systematic optimization of next-generation ionizable lipids for mRNA vaccines, gene editing (CRISPR-Cas9) therapeutics, and RNA interference-based treatments.
–20 °C, sealed under inert atmosphere, protected from light and moisture
Why Cosperpharm?
When your ionizable lipid synthesis or LNP formulation program requires a high-purity, reliably sourced amino alcohol ester building block, Cosperpharm delivers Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester with the documentation depth, supply consistency, and technical guidance that medicinal chemists and formulation scientists demand.
Certified purity for reproducible lipid synthesis. Each batch of Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester undergoes rigorous HPLC purity verification to ensure consistent quality. Given the presence of the secondary amine—which can undergo oxidation or premature alkylation—and the ester linkage—which is susceptible to hydrolysis—careful analytical characterization is essential to confirm the integrity of all functional groups prior to use in multi-step lipidoid synthesis.
Documentation structured for your research records. Every shipment of Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester includes a comprehensive Certificate of Analysis (COA) with batch-specific HPLC purity data and analytical traces. Our documentation is formatted for direct incorporation into your laboratory notebooks, publications, or patent filings, with DMF-ready quality statements available upon request.
Scalable supply with transparent timelines. Cosperpharm provides Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester in quantities ranging from milligram amounts for initial screening and reaction optimization to multi-gram batches for scaled-up lipid library synthesis and formulation development. Lead times are confirmed at the point of inquiry, enabling you to align procurement with research milestones.
Technical guidance on handling and lipid chemistry. Our application scientists possess deep knowledge of amino alcohol ester chemistry and the handling of ionizable lipid intermediates. They can provide practical guidance on storage, acylation conditions, and compatibility of Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester with common synthetic transformations, including esterification of the terminal hydroxyl group and subsequent derivatization of the secondary amine.
Global logistics with complete documentation. Cosperpharm ships Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester to academic laboratories, pharmaceutical companies, and CROs worldwide, with all customs paperwork provided. Appropriate temperature-controlled packaging is used to maintain product integrity during transit.
FAQ
Q1: How should Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester be stored?
A: For long-term integrity, store at –20 °C in a tightly sealed container under an inert atmosphere of nitrogen or argon, protected from light and moisture. The secondary amine is susceptible to oxidation, and the ester linkage may undergo slow hydrolysis under humid conditions. Allow the sealed container to equilibrate to ambient temperature before opening.
Q2: What are the primary research applications of this compound?
A: Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester is primarily used as a synthetic intermediate in the construction of ionizable lipid libraries for LNP-mediated mRNA and siRNA delivery. The secondary amine provides pH-responsive endosomal escape functionality, and the branched ester tail promotes fusogenic molecular geometry. Structurally related lipid compounds are pivotal in creating nucleic acid delivery systems and form crucial components of nanolipid particles used for delivery vectors .
Application Scenarios
Ionizable Lipid Synthesis for mRNA Delivery
Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester serves as a key synthetic intermediate in the construction of ionizable lipids for mRNA-LNP formulations, including vaccine and therapeutic applications. The secondary amine provides the pH-responsive ionizable center critical for endosomal escape.
Lipidoid Library Combinatorial Synthesis
Employed as a versatile building block in the combinatorial construction of structurally diverse lipidoid libraries, where the secondary amine can be derivatized with various electrophiles to generate libraries for systematic structure–activity relationship studies.
siRNA and Gene Silencing Delivery Systems
Used in the synthesis of ionizable lipids formulated into LNPs for siRNA delivery, where efficient endosomal escape mediated by the protonatable amine is essential for achieving potent gene knockdown.
CRISPR-Cas9 Ribonucleoprotein Delivery
Serves as a precursor in the development of biodegradable ionizable lipids for the co-delivery of Cas9 mRNA and single guide RNA (sgRNA) or for direct ribonucleoprotein delivery in gene editing applications.
The well-defined structure and multiple sites for derivatization make Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester a versatile platform for systematically varying the ester tail length, branching, and head group composition to optimize delivery efficiency and tissue tropism.
Endosomal Escape Mechanism Studies
Used as a model ionizable lipid component in biophysical investigations of pH-dependent membrane fusion, lipid phase transitions (lamellar to HII), and the molecular determinants of endosomal escape efficiency.
Contact Us
Ready to evaluate Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester for your ionizable lipid research program? We’ll put together a tailored quote as soon as we hear from you.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.
Privacy Policy